Govt plans to launch cheaper biosimilars for diabetes, cancerPost published:July 3, 2017Post category:Industry NewsThe plan to launch cheaper biosimilar drugs is in congruence with the govt’s affordable healthcare policy and makes India’s biotech industry globally competitive Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostTata Realty, StanChart PE JV buys Thane-Belapur land for Rs325 crore Next PostPharma firms yet to begin billing under new GST rates You Might Also Like Punjab National Bank planning QIP to raise $250-300 million October 17, 2017 ControlSoft announces acquisition of eSimulation and DxT3 January 11, 2019 Trai proposes changes in mobile number portability rules to curb request rejection August 16, 2017